AlphaFold predicted structure
D2HGDH · Q8N465

Mean pLDDT
92.4/ 100
Very high
521 residues
Confidence breakdown
- Very high(≥ 90)90%
- Confident(70–90)1%
- Low(50–70)0%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
D-2-hydroxyglutarate dehydrogenase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Early onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalInherited white matter disorders
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalWhite matter disorders and cerebral calcification - narrow panel
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
DDG2P
BIALLELIC, autosomal or pseudoautosomal+3 more panels — install the extension to see the full list inline on any page.
D-2-hydroxyglutaric aciduria
asthma
allergic rhinitis
allergic disease
L-2-hydroxyglutaric aciduria
Bilateral tonic-clonic seizure
Eczematoid dermatitis
childhood onset asthma
adult onset asthma
atopic eczema
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
D-2-hydroxyglutarate dehydrogenase, mitochondrial
Catalyzes the oxidation of D-2-hydroxyglutarate (D-2-HG) to alpha-ketoglutarate (PubMed:15070399, PubMed:15609246, PubMed:16037974, PubMed:20020533, PubMed:33431826). Also catalyzes the oxidation of other D-2-hydroxyacids, such as D-malate (D-MAL) and D-lactate (D-LAC) (PubMed:33431826). Exhibits high activities towards D-2-HG and D-MAL but a very weak activity towards D-LAC (PubMed:33431826)
D2HGDH · Q8N465

Mean pLDDT
92.4/ 100
Very high
521 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0